Using this approach, we investigated the effects of KMO inhibition on seizures, depressive-like behaviors, and cognitive function in epileptic mice, thereby providing novel insights and a robust scientific foundation for developing therapeutic strategies targeting epilepsy-associated depression. Here, KMO is linked to depressive symptom measurement.